首页> 美国卫生研究院文献>Nucleic Acids Research >A branch-migration based fluorescent probe for straightforward sensitive and specific discrimination of DNA mutations
【2h】

A branch-migration based fluorescent probe for straightforward sensitive and specific discrimination of DNA mutations

机译:基于分支迁移的荧光探针可直接敏感和特异性地识别DNA突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Genetic mutations are important biomarkers for cancer diagnostics and surveillance. Preferably, the methods for mutation detection should be straightforward, highly specific and sensitive to low-level mutations within various sequence contexts, fast and applicable at room-temperature. Though some of the currently available methods have shown very encouraging results, their discrimination efficiency is still very low. Herein, we demonstrate a branch-migration based fluorescent probe (BM probe) which is able to identify the presence of known or unknown single-base variations at abundances down to 0.3%-1% within 5 min, even in highly GC-rich sequence regions. The discrimination factors between the perfect-match target and single-base mismatched target are determined to be 89–311 by measurement of their respective branch-migration products via polymerase elongation reactions. The BM probe not only enabled sensitive detection of two types of EGFR-associated point mutations located in GC-rich regions, but also successfully identified the BRAF V600E mutation in the serum from a thyroid cancer patient which could not be detected by the conventional sequencing method. The new method would be an ideal choice for high-throughput in vitro diagnostics and precise clinical treatment.
机译:遗传突变是癌症诊断和监测的重要生物标记。优选地,用于突变检测的方法应该是直接的,高度特异性的并且对各种序列范围内的低水平突变敏感,快速并且在室温下适用。尽管一些当前可用的方法显示出令人鼓舞的结果,但是它们的判别效率仍然很低。本文中,我们展示了一种基于分支迁移的荧光探针(BM探针),即使在高度GC富集的序列中,该探针也能在5分钟内以低至0.3%-1%的丰度识别已知或未知的单碱基变异的存在。地区。通过聚合酶延伸反应测量它们各自的分支迁移产物,可以确定完全匹配靶标和单碱基错配靶标之间的区分因子为89-311。 BM探针不仅能够灵敏地检测位于GC丰富区域的两种与EGFR相关的点突变,而且还成功鉴定了甲状腺癌患者血清中的BRAF V600E突变,而常规测序方法无法检测到该突变。新方法将是高通量体外诊断和精确临床治疗的理想选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号